|
⚲
|
| Keyboard |
| Harrison Rosemary
✚
|
|
|---|---|
| CIK # | 0001838046 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001838046] | |
| 4 | [0001838046] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Harrison Rosemary | |
| TCR2 Therapeutics Inc | |
| Trillium Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2023-06-01 | Disposed to issuer | 76,930 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2023-06-01 | Disposed to issuer | 191,102 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Restricted Stock Unit · derivative
|
2023-06-01 | Disposed to issuer | 12,822 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Restricted Stock Unit (Right to Buy) · derivative
|
2022-12-15 | Grant | 12,822 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2022-12-15 | Grant | 76,930 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2022-01-10 | Grant | 191,102 | $0.00 | |
|
Trillium Therapeutics Inc TRIL
Stock Option (Right to Buy) · derivative
|
2021-11-17 | Disposed to issuer | 180,000 | $0.00 | |
|
Trillium Therapeutics Inc TRIL
Common Shares
|
2021-11-17 | Disposed to issuer | 75 |